Epion Health Receives $4.5M Series A Funding from Deerfield Management
OneMedMarket is pleased to report that its member company Epion Health announced the closing of a $4.5M Series A financing round with Deerfield Management Company, a leading national venture fund.
Read more »8th Annual OneMedForum San Francisco: New Venue & Partnership Announced
OneMedForum announced that its 8th annual conference will move to the San Francisco Marriott Marquis, January 12-14, 2015. According to Brett Johnson, Founder and CEO, “This new venue is probably the most significant development in the nearly 8 years we’ve been doing the conference. Its central location and layout are ideal. It’s a perfect space for networking, partnering, exhibits, and company presentations occurring around a large central atrium. It offers a dramatic setting for the launch of OneMedMarket.
Read more »NanoViricides Opens New Facility in Shelton, CT for Production of Drug Candidates
NanoViricides, Inc. (NYSE MKT:NNVC) opened its new R&D and cGMP pilot manufacturing facility with U.S. Congressman Jim Himes performing the ribbon cutting to inaugurate the facility on July 21, 2014.
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. The company’s novel nanoviricide® class of drug candidates is designed to specifically attack enveloped virus particles and dismantle them.
Read more »